Skip to main content
. 2002 Nov;161(5):1849–1859. doi: 10.1016/S0002-9440(10)64461-6

Figure 7.

Figure 7.

A: Western blot analysis using anti-human C5a Ab: lane 1, molecular weight standards; lane 2, recombinant human C5a (100 ng); lane 3, supernatant fluids from PMA-stimulated rat AMs to which C5 (90 μg) was added and incubation was performed at 37°C for 4 hours; lane 4, similar to lane 3 with the exception that at the start of incubation SBTI (100 μg/ml) was added. B: Western blot using the same anti-human C5a Ab: lane 5, human C5a; lanes 6 to 9, supernatant fluids from PMA-stimulated AMs to which C5 (90 μg) had been added in the presence of 0 to 100 μg of SLPI/ml. Data are representative of two separate and independent experiments.